Ondansetron to prevent pancreatitis after ERCP
Treatments studied
Part of Digestive system clinical trials.
This trial tests whether ondansetron, a medicine that helps control nausea and vomiting, can reduce the risk of pancreatitis (inflammation of the pancreas) after an ERCP procedure. If you are scheduled for an ERCP and do not have certain health issues, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are scheduled for ERCP due to a suspected pancreas or bile duct problem.
- Your blood amylase and lipase levels are normal before the procedure.
- You do not have a history of pancreatitis before the ERCP.
- You have not had prior treatments on your bile or pancreatic duct opening (like cutting, stretching, or stenting).
- You are not pregnant or nursing.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This phase 3 trial tests duloxetine for preventing pancreatitis after ERCP in adults with normal baseline amylase/lipase and without certain comorbidities.
This study tests whether giving lidocaine during an ERCP procedure can lower the risk of a painful complication called pancreatitis. If you’re scheduled for ERCP with a “never-treated” opening, this trial may see if lidocaine helps you avoid post-procedure pancreas inflammation.
This Phase 3 study tests whether putting an anti-inflammatory medicine into the rectum (indomethacin) plus taking an immune-suppressing pill (tacrolimus) works better than using the two medicines in a different combination to prevent pancreatitis after an ERCP procedure. If you qualify, you may be assigned to one of the treatment options to lower your risk of post-ERCP pancreas inflammation.
This trial is studying how often pancreatitis happens after a common bile duct procedure called ERCP, and how a standard safety protocol might help prevent it. It aims to include people who need a therapeutic ERCP (treatment, not just diagnosis) to learn more about safe practices.
This trial tests whether giving extra IV fluids before, during, and after an ERCP procedure can help prevent a common complication called post-ERCP pancreatitis (inflammation of the pancreas). If you are scheduled for an ERCP, you may be eligible to participate.
This trial tests whether rinsing the pancreas with cold water during ERCP can reduce the risk of pancreatitis, a common complication. The treatment is added to the standard medicine (indomethacin) to see if it offers extra protection.
Hear when a new Pancreatic Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.